Citation 148792

LE BAIL,JC: POUGET,C: FAGNERE,C: BASLY,JP: CHULIA,AJ: HABRIOUX,G:. (2001). CHALCONES ARE POTEN INHIBITORS OF AROMATASE AND 17 BETA-HYDROXYSTEROIDDEHYDROXYSTERIOD DEHYDROGENASE ACTIVITIES.. 68(7)

Citation Details

Title	CHALCONES ARE POTEN INHIBITORS OF AROMATASE AND 17 BETA-HYDROXYSTEROIDDEHYDROXYSTERIOD DEHYDROGENASE ACTIVITIES.
Authors	LE BAIL,JC: POUGET,C: FAGNERE,C: BASLY,JP: CHULIA,AJ: HABRIOUX,G:
Year	2001
Volume	68
Issue	7

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	ACTIVE
2	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	INACTIVE
3	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-HYDROXY:	ACTIVE
4	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-HYDROXY:	ACTIVE
5	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
6	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
7	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
8	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
9	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	ACTIVE
10	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	INACTIVE
11	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,7-HYDROXY:	ACTIVE
12	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,7-HYDROXY:	ACTIVE
13	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
14	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
15	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIODICTYOL	ACTIVE
16	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIODICTYOL	INACTIVE
17	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	ACTIVE
18	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
19	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	INACTIVE
20	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	INACTIVE
21	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY:	INACTIVE
22	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY:	INACTIVE
23	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,4'-HYDROXY:	ACTIVE
24	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,4'-HYDROXY:	INACTIVE
25	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,4-HYDROXY:	INACTIVE
26	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,4-HYDROXY:	ACTIVE
27	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4'-DIHYDROXY:	INACTIVE
28	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4'-DIHYDROXY:	ACTIVE
29	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4-DIHYDROXY:	INACTIVE
30	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4-DIHYDROXY:	INACTIVE
31	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN,ISO:	ACTIVE
32	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN,ISO:	ACTIVE
33	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	None	None
34	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY-4'-METHOXY:	INACTIVE
35	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY-4'-METHOXY:	INACTIVE
36	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	PINOSTROBIN CHALCONE	None
37	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOSTROBIN CHALCONE	ACTIVE
38	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOSTROBIN CHALCONE	INACTIVE
39	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	NARINGENIN CHALCONE	None
40	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN CHALCONE	ACTIVE
41	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN CHALCONE	INACTIVE
42	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	ERIODICTYOL CHALCONE	None
43	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIODICTYOL CHALCONE	ACTIVE
44	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIODICTYOL CHALCONE	INACTIVE
45	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	HESPERETIN CHALCONE	None
46	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN CHALCONE	ACTIVE
47	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN CHALCONE	INACTIVE

Citation 148792

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1